pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Hematology · news · pharmadog
← back to Hematology
News · Hematology
407
stories
13d
Why Big Pharma is chasing the industry’s most-powerful supercomputer
biopharma dive
13d
Ensoma sheds more staff, pauses preclinical programs to home in on lead gene therapy
fiercebiotech
14d
BioVie shares halve on murky Parkinson’s disease readout
biospace
15d
Opinion: STAT+: Stop asking if AI is good for medicine
stat
15d
Braveheart charges past expectations with $382.5M IPO to fund cardio drug from Hengrui
fiercebiotech
15d
Cardiac drug developer Braveheart banks more than $382M in IPO
biopharma dive
15d
Lilly climbs, Novo falls as obesity drug battle intensifies
biopharma dive
15d
No deal between AstraZeneca and BMS, senior source insists: Reuters
biospace
15d
Novo CEO sees innovation as a matter of survival amid pipeline setbacks
biospace
15d
A COPD drug from China draws $115M in venture funding
biopharma dive
15d
Rumors of biggest pharma merger ever drop amid Q2 earnings, contentious FDA adcomms
biospace
16d
‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth
fiercebiotech
16d
MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them
stat
16d
5 NextGen winners who went public this year (and which ones are hiring)
biospace
16d
Victory Medical Center Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels
fda medwatch
16d
Fresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist® Prefilled Syringe Due to Labeling Mix-up
fda medwatch
16d
Novo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed data
fiercebiotech
16d
Pfizer CEO defends $7B bolt-on M&A strategy as peers rush to buy
biospace
16d
As portfolio erodes, BMS stands to gain a lot from rumored AstraZeneca merger
biospace
16d
Pfizer cuts $2.5B more across R&D, manufacturing in ongoing restructure
biospace
17d
Liebel-Flarsheim Company, LLC Issues Recall of OPTIRAY Imaging Bulk Package - 350, 500mL, Vial, Nationwide and Mexico Due to Presence of Particulate Matter
fda medwatch
17d
An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.
biopharma dive
17d
BioNTech picks Sobi CEO Oelkers to lead as founders plot new mRNA biotech
biospace
18d
Convenience Kit Correction: Medical Action Industries Issues Correction for Kits Containing Recalled Namic Manifolds
fda medwatch
20d
Novo setback casts doubt on a new way to treat heart disease
biopharma dive
20d
Sanofi to ‘rebuild trust’ with Regeneron; Apnimed adds to string of ‘upsized’ biotech IPOs
biopharma dive
20d
Karyopharm shares crater on second Phase 3 flop for Xpovio in endometrial cancer
endpoints
21d
Syphilis spreads while researchers contend with federal constraints and a drug shortage
stat
21d
Catheter Introducer Kit Recall: Abiomed Removes 14Fr Low Profile Introducer Kits
fda medwatch
21d
J&J nabs option to buy ‘in vivo’ CAR-T maker Sail for nearly $2.6B
biopharma dive
← prev
page 3 of 14
next →
